Construct: ORF TRCN0000488555
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF021654.1_s317c1
- DNA Barcode:
- GGCGAATAATCCAGTCCTGCTCTC
- Epitope Tag:
- V5 (not translated due to prior stop codon)
- Notes:
- Has stop codon in insert
Originally Annotated References:
- Gene:
- PRKAG2 (51422)
Vector Information:
- Vector Backbone:
- pLX_317
- Pol II Cassette 1:
- SV40-PuroR
- Pol II Cassette 2:
- EF1a-TRCN0000488555
- Selection Marker:
- PuroR
- Visible Reporter:
- n/a
- Epitope Tag:
- V5
Current transcripts matched by this ORF:
Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
---|---|---|---|---|---|---|---|---|
1 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | NM_016203.4 | 100% | 100% | |
2 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_017012269.1 | 99.8% | 99.8% | 752_753insAGC |
3 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_011516283.1 | 94.3% | 91.2% | (many diffs) |
4 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_011516284.1 | 94.1% | 91.1% | (many diffs) |
5 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | NM_001040633.1 | 92.2% | 92.2% | 0_1ins132 |
6 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_017012270.1 | 92.2% | 92.2% | 0_1ins132 |
7 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_017012271.2 | 92% | 92% | 0_1ins132;620_621insAGC |
8 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_017012272.1 | 92% | 92% | 0_1ins132;620_621insAGC |
9 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_005250002.4 | 90.9% | 90.1% | (many diffs) |
10 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_006716021.2 | 85.8% | 82.4% | (many diffs) |
11 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_011516282.1 | 85.7% | 82.3% | (many diffs) |
12 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_005250004.4 | 83.8% | 83.1% | (many diffs) |
13 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_024446786.1 | 83.8% | 83.1% | (many diffs) |
14 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_017012268.2 | 83.6% | 82.9% | (many diffs) |
15 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | NM_001363698.1 | 74.4% | 73.7% | (many diffs) |
16 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | NM_001304527.1 | 74.2% | 73.6% | (many diffs) |
17 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_005250006.5 | 67.6% | 66.2% | (many diffs) |
18 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | NM_001304531.1 | 57.6% | 57.6% | 0_1ins723 |
19 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | NM_024429.1 | 57.6% | 57.6% | 0_1ins723 |
20 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_024446789.1 | 57.6% | 57.6% | 0_1ins723 |
21 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_017012276.2 | 57.4% | 57.4% | 0_1ins723;29_30insAGC |
22 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_017012277.2 | 56.1% | 55.8% | 0_1ins745;2T>G;6_6delCinsGAA |
23 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_017012278.1 | 54.1% | 54.1% | 0_1ins783 |
24 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_017012279.2 | 54.1% | 54.1% | 0_1ins783 |
25 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_017012280.2 | 54.1% | 54.1% | 0_1ins783 |
26 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_017012281.2 | 54.1% | 54.1% | 0_1ins783 |
27 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_011516285.2 | 52.1% | 51.4% | (many diffs) |
28 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_024446787.1 | 52.1% | 51.4% | (many diffs) |
29 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_017012274.2 | 51.9% | 51.2% | (many diffs) |
30 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_024446788.1 | 51.9% | 51.2% | (many diffs) |
31 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_011516286.2 | 50.7% | 49.8% | (many diffs) |
32 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_011516287.1 | 48.9% | 48.2% | (many diffs) |
33 | human | 51422 | PRKAG2 | protein kinase AMP-activate... | XM_017012275.2 | 48.9% | 48.2% | (many diffs) |
34 | mouse | 108099 | Prkag2 | protein kinase, AMP-activat... | XM_006535611.3 | 89.3% | 93.6% | (many diffs) |
35 | mouse | 108099 | Prkag2 | protein kinase, AMP-activat... | NM_145401.2 | 89.1% | 93.4% | (many diffs) |
36 | mouse | 108099 | Prkag2 | protein kinase, AMP-activat... | XM_006535612.3 | 82.7% | 86.8% | (many diffs) |
37 | mouse | 108099 | Prkag2 | protein kinase, AMP-activat... | XM_017320595.1 | 76.9% | 80.3% | (many diffs) |
38 | mouse | 108099 | Prkag2 | protein kinase, AMP-activat... | NM_001310480.1 | 68.8% | 69.7% | (many diffs) |
39 | mouse | 108099 | Prkag2 | protein kinase, AMP-activat... | XM_006535614.3 | 65.9% | 68.7% | (many diffs) |
40 | mouse | 108099 | Prkag2 | protein kinase, AMP-activat... | NM_001170555.1 | 52.8% | 56.7% | (many diffs) |
41 | mouse | 108099 | Prkag2 | protein kinase, AMP-activat... | NM_001170556.1 | 52.7% | 56.5% | (many diffs) |
42 | mouse | 108099 | Prkag2 | protein kinase, AMP-activat... | XM_011249740.1 | 51.9% | 55.5% | (many diffs) |
43 | mouse | 108099 | Prkag2 | protein kinase, AMP-activat... | XM_017320596.1 | 51.9% | 55.3% | (many diffs) |
44 | mouse | 108099 | Prkag2 | protein kinase, AMP-activat... | XR_880821.2 | 40.5% | (many diffs) | |
45 | mouse | 108099 | Prkag2 | protein kinase, AMP-activat... | XR_389738.3 | 39.8% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 69
- ORF end:
- 1776
- ORF length:
- 1707
- Sequence:
-
1 tcttccattt caggtgtcgt gaggctagca tcgattgatc aacaagtttg tacaaaaaag 61 caggcaccat gggaagcgcg gttatggaca ccaagaagaa aaaagatgtt tccagccccg 121 gcgggagcgg cggcaagaaa aatgccagcc agaagaggcg ttcgctgcgc gtgcacattc 181 cggacctgag ctccttcgcc atgccgctcc tggacggaga cctggagggt tccggaaagc 241 attcctctcg aaaggtggac agccccttcg gcccgggcag cccctccaaa gggttcttct 301 ccagaggccc ccagccccgg ccctccagcc ccatgtctgc acctgtgagg cccaagacca 361 gccccggctc tcccaaaacc gtgttcccgt tctcctacca ggagtccccg ccacgctccc 421 ctcgacgcat gagcttcagt gggatcttcc gctcctcctc caaagagtct tcccccaact 481 ccaaccctgc tacctcgccc gggggcatca ggtttttctc ccgctccaga aaaacctccg 541 gcctctcctc ctctccgtca acacccaccc aagtgaccaa gcagcacacg tttcccctgg 601 aatcctataa gcacgagcct gaacggttag agaatcgcat ctatgcctcg tcttcccccc 661 cggacacagg gcagaggttc tgcccgtctt ccttccagag cccgaccagg cctccactgg 721 catcaccgac acactatgct ccctccaaag ccgcggcgct ggcggcggcc ctgggacccg 781 cggaagccgg catgctggag aagctggagt tcgaggacga agcagtagaa gactcagaaa 841 gtggtgttta catgcgattc atgaggtcac acaagtgtta tgacatcgtt ccaaccagtt 901 caaagcttgt tgtctttgat actacattac aagttaaaaa ggccttcttt gctttggtag 961 ccaacggtgt ccgagcagcg ccactgtggg agagtaaaaa acaaagtttt gtaggaatgc 1021 taacaattac agatttcata aatatactac atagatacta taaatcacct atggtacaga 1081 tttatgaatt agaggaacat aaaattgaaa catggaggga gctttattta caagaaacat 1141 ttaagccttt agtgaatata tctccagatg caagcctctt cgatgctgta tactccttga 1201 tcaaaaataa aatccacaga ttgcccgtta ttgaccctat cagtgggaat gcactttata 1261 tacttaccca caaaagaatc ctcaagttcc tccagctttt tatgtctgat atgccaaagc 1321 ctgccttcat gaagcagaac ctggatgagc ttggaatagg aacgtaccac aacattgcct 1381 tcatacatcc agacactccc atcatcaaag ccttgaacat atttgtGGAA AGACGAATAT 1441 CAGCTCTGCC TGTTGTGGAT GAGTCAGGAA AAGTTGTAGA TATTTATTCC AAATTTGATG 1501 TAATTAATCT TGCTGCTGAG AAAACATACA ATAACCTAGA TATCACGGTG ACCCAGGCCC 1561 TTCAGCACCG TTCACAGTAT TTTGAAGGTG TTGTGAAGTG CAATAAGCTG GAAATACTGG 1621 AGACCATCGT GGACAGAATA GTAAGAGCTG AGGTCCATCG GCTGGTGGTG GTAAATGAAG 1681 CAGATAGTAT TGTGGGTATT ATTTCCCTGT CGGACATTCT GCAAGCCCTG ATCCTCACAC 1741 CAGCAGGTGC CAAACAAAAG GAGACAGAAA CGGAGTAGAA CCCAGCTTTC TTGTACAAAG 1801 TGGTTGATAT CGGTAAGCCT ATCCCTAACC CTCTCCTCGG TCTCGATTCT ACGTAGTAAT 1861 GAACTAGTCC GTAACTTGAA AGTATTTCGA TTTCTTGGCT TTATATATCT TGTGGAAAGG 1921 ACGAGGCGAA TAATCCAGTC CTGCTCTCAC GCGTTAAGTC gacaatcaac ctctggatta 1981 caaaatttgt gaaagatt